Liver failure in a patient receiving rosiglitazone therapy
- PMID: 16409577
- DOI: 10.1111/j.1464-5491.2006.01791.x
Liver failure in a patient receiving rosiglitazone therapy
Similar articles
-
Pioglitazone-associated fulminant hepatic failure.Am J Gastroenterol. 2002 Feb;97(2):502-3. doi: 10.1111/j.1572-0241.2002.05516.x. Am J Gastroenterol. 2002. PMID: 11866308 No abstract available.
-
Diabetes drug Rezulin: take it, but take precautions.Health News. 1999 May 10;5(6):7. Health News. 1999. PMID: 10546576 No abstract available.
-
Fatal liver failure associated with pioglitazone.BMJ. 2004 Aug 21;329(7463):429. doi: 10.1136/bmj.329.7463.429. BMJ. 2004. PMID: 15321899 Free PMC article. No abstract available.
-
Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?J Fam Pract. 2005 Aug;54(8):723-4. J Fam Pract. 2005. PMID: 16061064 Review. No abstract available.
-
The rough road for rosiglitazone.Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):113-7. doi: 10.1097/MED.0b013e3282f8b483. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18316944 Review.
Cited by
-
Rosiglitazone for type 2 diabetes mellitus.Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD006063. doi: 10.1002/14651858.CD006063.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636824 Free PMC article.
-
Important elements for the diagnosis of drug-induced liver injury.Clin Gastroenterol Hepatol. 2010 May;8(5):463-70. doi: 10.1016/j.cgh.2010.02.008. Epub 2010 Feb 17. Clin Gastroenterol Hepatol. 2010. PMID: 20170750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical